Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Opus Genetics (IRD) Accumulated Depreciation & Amortization (2019 - 2024)

Opus Genetics has reported Accumulated Depreciation & Amortization over the past 8 years, most recently at $25000.0 for Q3 2024.

  • Quarterly Accumulated Depreciation & Amortization rose 13.64% to $25000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $25000.0 through Sep 2024, up 13.64% year-over-year, with the annual reading at $25000.0 for FY2023, 31.58% up from the prior year.
  • Accumulated Depreciation & Amortization was $25000.0 for Q3 2024 at Opus Genetics, roughly flat from $25000.0 in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $298736.0 in Q3 2020 and troughed at $11000.0 in Q4 2020.
  • The 5-year median for Accumulated Depreciation & Amortization is $20000.0 (2023), against an average of $61468.2.
  • Year-over-year, Accumulated Depreciation & Amortization skyrocketed 266.67% in 2020 and then plummeted 95.73% in 2021.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $11000.0 in 2020, then surged by 36.36% to $15000.0 in 2021, then grew by 26.67% to $19000.0 in 2022, then surged by 31.58% to $25000.0 in 2023, then changed by 0.0% to $25000.0 in 2024.
  • Per Business Quant, the three most recent readings for IRD's Accumulated Depreciation & Amortization are $25000.0 (Q3 2024), $25000.0 (Q2 2024), and $25000.0 (Q1 2024).